INHIBITOREN VON CXCR2
European patent · EP3377059 · In force
Register entry
- Publication number
- EP3377059
- Application number
- EP16867099
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 17, 2016
- Published
- Sep 26, 2018
- Granted
- Oct 21, 2020
- Protection ends at the latest
- Nov 16, 2036
- Next annual fee due
- Nov 30, 2026
- IPC classes
- A61K 31/407 (2006.01)A61K 31/404 (2006.01)A61K 31/5377 (2006.01)A61P 11/00 (2006.01)A61P 17/06 (2006.01)A61P 35/00 (2006.01)A61P 37/00 (2006.01)
- Priority
- US 201562257529 P 19.11.2015
- PCT application
- PCT/US2016/062427 17.11.2016
- PCT publication
- WO2017/087610 26.05.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Dec 6, 2022
Change
Published in Swissreg on 06.12.2022
- Jan 13, 2021
Agent entered
- Representative
- TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly
Published in Swissreg on 13.01.2021
- Oct 21, 2020
Granted
Published in Swissreg on 21.10.2020
Parties
Inventor
Palo Alto, CA 94306, US
Mountain View, CA 94043, US
San Francisco, CA 94121, US
Dublin, CA 94568-4298, US
E. Palo Alto, CA 94303, US
Los Altos, CA 94024, US
Mountian View, CA, US
Sunnyvale, CA 94086, US
Foster City, CA 94404, US
Cupertino, CA 95014, US
Mountain View, CA 94041, US
Palo Alto, CA 94303, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.